EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Marine Antimicrobial Peptide as a Promising Alternative to Polymyxin B

Victoria N Safronova iD, Vladislav A Lushpa iD, Victoria O Shipunova iD, Marta V Volovik iD, Kira L Dobrochaeva iD, Roman N Kruglikov, Ilia A Bolosov iD, Dmitrii E Dashevskii, Alexey V Mishin iD, Oleg V Batishchev iD, Olga V Korobova, Alexander I Borzilov iD und 5 weitere

Marine Drugs · 2026

DOI: 10.3390/md24050154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2026. Verfasst von Victoria N Safronova und 16 weiteren Autor:innen. Beteiligte Einrichtung: M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia. Hauptthemen laut MEDLINE: Polymyxin B, Anti-Bacterial Agents, Antimicrobial Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise in antimicrobial resistance represents a significant challenge to global health. The reason partially lies in an inappropriate use of conventional antibiotics and the subsequent rapid spread of multidrug-resistant pathogen strains. This emergency requires an urgent search for conceptually new antimicrobial agents. A viable alternative to conventional antibiotics is antimicrobial peptides (AMPs), which are ribosomally synthesized molecules with considerable potential as next-generation anti-infectious therapeutics. Previously, we have reported on the β-hairpin peptide Ap9, an analog of abarenicin from the marine polychaeta Abarenicola pacifica, with potent activity against key Gram-negative pathogens. Here, it is shown that Ap9 acts in a manner resembling polymyxin B, namely via interaction with lipopolysaccharide (LPS), and retains its activity against polymyxin-resistant isolates without observed cross-resistance, and causes insignificant damage in cytoplasmic membrane at bactericidal concentrations. NMR spectroscopy reveals that LPS binding induces a conformational rearrangement of Ap9, its dimer formation, and local structural remodeling of the peptide region (residues 8–12) into 310-helix. Bacterial resistance to Ap9 was found to be relatively low with a reduced susceptibility associated with infrequent genetic alterations, such as the mutation in lptD or the deletion in mlaA. Furthermore, Ap9 demonstrates a favorable tolerability, a wider therapeutic window than that of polymyxin B, and a sufficiently long half-life through the systemic use, as well as in vivo efficacy in murine models of Gram-negative infections, including sepsis caused by the mcr-1-harboring Escherichia coli strain. The obtained results point to Ap9 as a promising candidate for further preclinical studies aimed at development of an alternative to polymyxins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyxin BAnti-Bacterial AgentsAntimicrobial PeptidesAnimalsLipopolysaccharidesMicrobial Sensitivity TestsGram-Negative BacteriaDrug Resistance, BacterialAquatic OrganismsEscherichia coli

Stichwörter der Autor:innen

Gram-negative bacteriaantibioticantimicrobial peptidedrug resistancein vivo studieslipopolysaccharidepolymyxin

Substanzen

Polymyxin BAnti-Bacterial AgentsAntimicrobial PeptidesLipopolysaccharides

Autor:innen und Institutionen

  • M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Moscow Center for Advanced Studies, 123592 Moscow, Russia.
  • Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences, 119071 Moscow, Russia.
  • State Research Center for Applied Microbiology & Biotechnology, 142279 Obolensk, Russia.
  • Branch of M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 142290 Pushchino, Russia.
  • Department of Biotechnology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.

ORCID-Profile: Victoria N Safronova, Vladislav A Lushpa, Victoria O Shipunova, Marta V Volovik, Kira L Dobrochaeva, Ilia A Bolosov, Alexey V Mishin, Oleg V Batishchev, Alexander I Borzilov, Igor A Dyachenko, Eduard V Bocharov, Pavel V Panteleev, Tatiana V Ovchinnikova

Förderung

  • Russian Science Foundation

Zitieren

APA

Safronova, V. N., Lushpa, V. A., Shipunova, V. O., Volovik, M. V., Dobrochaeva, K. L., Kruglikov, R. N., Bolosov, I. A., Dashevskii, D. E., Mishin, A. V., Batishchev, O. V., Korobova, O. V., Borzilov, A. I., Slashcheva, G. A., Dyachenko, I. A., Bocharov, E. V., Panteleev, P. V., & Ovchinnikova, T. V. (2026). Marine Antimicrobial Peptide as a Promising Alternative to Polymyxin B. Marine Drugs. https://doi.org/10.3390/md24050154

Vancouver

Safronova VN, Lushpa VA, Shipunova VO, Volovik MV, Dobrochaeva KL, Kruglikov RN, et al. Marine Antimicrobial Peptide as a Promising Alternative to Polymyxin B. Marine Drugs. 2026. doi:10.3390/md24050154

BibTeX
@article{Safronova2026,
  author = {Safronova, Victoria N and Lushpa, Vladislav A and Shipunova, Victoria O and Volovik, Marta V and Dobrochaeva, Kira L and Kruglikov, Roman N and Bolosov, Ilia A and Dashevskii, Dmitrii E and Mishin, Alexey V and Batishchev, Oleg V and Korobova, Olga V and Borzilov, Alexander I and Slashcheva, Gulsara A and Dyachenko, Igor A and Bocharov, Eduard V and Panteleev, Pavel V and Ovchinnikova, Tatiana V},
  title = {Marine Antimicrobial Peptide as a Promising Alternative to Polymyxin B},
  journal = {Marine Drugs},
  year = {2026},
  doi = {10.3390/md24050154}
}
Kostenlos starten →